What We Cover
Not the pitch. The paperwork, the structure, and the arithmetic underneath it.
What issuers must disclose under Reg CF and Reg A+, what the financial statements are actually reviewed or audited to, and which sections repay careful reading.
SAFEs, convertible notes, valuation caps, discounts, preferred versus common, and voting rights. Two investments at the same headline valuation can be worth very different amounts.
Liquidation preferences, dilution across later rounds, transfer restrictions, and the plain fact that private shares usually have no market to sell into.
We do not rate, rank, or recommend individual offerings, and we do not run a “deal of the week”. Publications that do tend to be paid by the issuer, and the incentive is impossible to reconcile with telling readers a deal is weak.
We do not host or sell securities, we are not a funding portal, and we take no commission on any raise. If you want to know where current offerings are listed, the SEC’s EDGAR system and the registered funding portals are the primary sources — not us.
Most early-stage companies fail, and most early-stage investments return nothing. Regulation CF and Reg A+ investments are illiquid, frequently have no secondary market at all, and can be impossible to value or sell for years. Money committed to this asset class should be money you can afford to lose entirely.
We say this at the top rather than in a footnote because a publication that teaches diligence while implying the odds are good is not teaching diligence.
Nothing here is a recommendation to invest in any offering. We explain how these instruments work; we do not tell you which to buy, and understanding a structure is not the same as it being suitable for you. See our disclaimer.